Earnings Call · Q2 FY2025·2025-07-24

Q2 25EPS +8.06%·Rev n/aQ1 25EPS +6.67%·Rev n/aQ4 24EPS +6.38%·Rev n/aQ3 24EPS +13.56%·Rev n/a⚠ consensus missing

Edwards Lifesciences Corp EW

Mark Wilterding — Senior Vice President, Global Finance

Bernard Zovighian — Chief Executive Officer

Scott Ullem — Chief Financial Officer

+5.5%1d on move date+5.1% vs SPY3d+6.2%5d+4.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EW calls or request research access.

More EW calls Browse calls Request research access